159 related articles for article (PubMed ID: 1709804)
1. The use of a low molecular weight heparinoid (Org 10172) for extracorporeal procedures in patients with heparin dependent thrombocytopenia and thrombosis.
Rowlings PA; Mansberg R; Rozenberg MC; Evans S; Murray B
Aust N Z J Med; 1991 Feb; 21(1):52-4. PubMed ID: 1709804
[TBL] [Abstract][Full Text] [Related]
2. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
[No Abstract] [Full Text] [Related]
3. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
[TBL] [Abstract][Full Text] [Related]
4. Clinical use of heparin fractions, fragments, and heparinoids.
Messmore HL
Semin Thromb Hemost; 1985 Apr; 11(2):208-12. PubMed ID: 2412297
[No Abstract] [Full Text] [Related]
5. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
[TBL] [Abstract][Full Text] [Related]
6. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid.
Harenberg J; Zimmermann R; Schwarz F; Kübler W
Lancet; 1983 Apr; 1(8331):986-7. PubMed ID: 6132291
[No Abstract] [Full Text] [Related]
7. Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Cola C; Ansell J
Am Heart J; 1990 Feb; 119(2 Pt 1):368-74. PubMed ID: 1689094
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172).
Magnani HN
Thromb Haemost; 1993 Oct; 70(4):554-61. PubMed ID: 7509508
[TBL] [Abstract][Full Text] [Related]
9. Can low molecular weight heparins and heparinoids be safely given to patients with heparin-induced thrombocytopenia syndrome?
Kikta MJ; Keller MP; Humphrey PW; Silver D
Surgery; 1993 Oct; 114(4):705-10. PubMed ID: 7692613
[TBL] [Abstract][Full Text] [Related]
10. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Jackson MR; Danby CA; Alving BM
Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy associated with lupus anticoagulant and heparin induced thrombocytopenia: management with a low molecular weight heparinoid.
van Besien K; Hoffman R; Golichowski A
Thromb Res; 1991 Apr; 62(1-2):23-9. PubMed ID: 1712988
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).
Greinacher A; Eckhardt T; Mussmann J; Mueller-Eckhardt C
Thromb Res; 1993 Jul; 71(2):123-6. PubMed ID: 7689764
[TBL] [Abstract][Full Text] [Related]
13. Haemofiltration/haemodialysis in patients with heparin-associated thrombocytopenia.
Chong BH; Jacques T
Intensive Care Med; 1991; 17(7):437. PubMed ID: 1774405
[No Abstract] [Full Text] [Related]
14. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
[TBL] [Abstract][Full Text] [Related]
15. A comparative review of the adverse effect profiles of heparins and heparinoids.
Borris LC; Lassen MR
Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
[TBL] [Abstract][Full Text] [Related]
16. Use of a low molecular weight preparation of heparin--ORG 10172 (Lomoparan) in the critically ill.
John G; Shehabi Y; Mudaliar Y
Anaesth Intensive Care; 1991 Nov; 19(4):588-91. PubMed ID: 1721505
[No Abstract] [Full Text] [Related]
17. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
Wilde MI; Markham A
Drugs; 1997 Dec; 54(6):903-24. PubMed ID: 9421696
[TBL] [Abstract][Full Text] [Related]
18. Heparin-associated thrombocytopenia: successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins.
Greinacher A; Drost W; Michels I; Leitl J; Gottsmann M; Kohl HJ; Glaser M; Mueller-Eckhardt C
Ann Hematol; 1992 Jan; 64(1):40-2. PubMed ID: 1310879
[TBL] [Abstract][Full Text] [Related]
19. [Heparin-induced thrombopenia and thrombosis].
Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
[TBL] [Abstract][Full Text] [Related]
20. Orgaran in heparin-induced thrombocytopenia.
Chong BH; Magnani HN
Haemostasis; 1992; 22(2):85-91. PubMed ID: 1379968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
